Jacobi Capital Management LLC Myriad Genetics Inc Transaction History

Jacobi Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$24.13 - $32.63 $916 - $1,239	-38 Closed	0 $0
Q2 2020 Aug 04, 2020	SELL	$10.69 - $16.49 $1,090 - $1,681	-102 Reduced 72.86%	38 $0
Q2 2020 Jul 27, 2020	BUY	$10.69 - $16.49 $1,496 - $2,308	140 New	140 $0
Q1 2020 Apr 24, 2020	SELL	$9.78 - $29.53 $391 - $1,181	-40 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$28.83 - $41.01 $1,153 - $1,640	40 New	40 $1,000

191

94.2M

280K

14.3K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.97B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Jacobi Capital Management LLC with notifications on news.